Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 8/20 | 0.70 |
| ▸ | FNTA | P49354 | 4/20 | 0.60 |
| ▸ | FNTB | P49356 | 4/20 | 0.60 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.58 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.56 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19388198 | 1.00 | NOD1 (0.70) | NOD1FNTAFNTBPGGT1BSLC6A5 | |
| SCHEMBL4741209 | 1.00 | NOD1 (0.70) | NOD1FNTAFNTBPGGT1BSLC6A5 | |
| SCHEMBL5664925 | 1.00 | NOD1 (0.70) | NOD1FNTAFNTBPGGT1BSLC6A5 | |
| SCHEMBL11418536 | 1.00 | NOD1 (0.70) | NOD1FNTAFNTBPGGT1BSLC6A5 | |
| SCHEMBL25188855 | 1.00 | NOD1 (0.70) | NOD1FNTAFNTBPGGT1BSLC6A5 | |
| SCHEMBL4741211 | 1.00 | NOD1 (0.70) | NOD1FNTAFNTBPGGT1BSLC6A5 | |
| SCHEMBL25264982 | 1.00 | NOD1 (0.70) | NOD1FNTAFNTBPGGT1BSLC6A5 | |
| SCHEMBL11426235 | 1.00 | NOD1 (0.70) | NOD1FNTAFNTBPGGT1BSLC6A5 | |
| SCHEMBL17204611 | 1.00 | NOD1 (0.70) | NOD1FNTAFNTBPGGT1BSLC6A5 | |
| SCHEMBL7180752 | 1.00 | NOD1 (0.70) | NOD1FNTAFNTBPGGT1BSLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250027938-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-01-23 | — | — | US | claimed |
| EP-4370919-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | Imperial College Innovations Limited (GB) | 2024-05-22 | — | — | EP | claimed |
| US-11559071-B2 | N-acyl-amino acid derivatives for improvement of the flavour profile of edible compositions | GIVAUDAN SA (CH) | 2023-01-24 | — | — | US | claimed |
| WO-2023285832-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-01-19 | — | — | WO | claimed |
| US-11319285-B2 | N-acylated methionine sulfoxides as food flavouring compounds | GIVAUDAN S.A. (CH) | 2022-05-03 | — | — | US | claimed |
| CN-110306213-B | Tin plating solution for solar cell and preparation method thereof | 广州三孚新材料科技股份有限公司 | 2020-08-04 | — | — | CN | claimed |
| CN-101367859-B | Fatty acid bile acid couplet and medical uses thereof | INST PHARM & TOXICOLOGY AMMS | 2011-05-11 | — | — | CN | claimed |
| CN-101367859-A | Fatty acid bile acid couplet and medical uses thereof | POISON MED INST PLA MED ACAD (CN) | 2009-02-18 | — | — | CN | claimed |
| EP-4662197-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2025-12-17 | — | — | EP | disclosed |
| CN-120053661-A | Hydrophilic fatty acid complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120053660-A | Hydrophilic complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-114808051-B | Tin plating solution for magnetic core inductance electroplating and preparation method thereof | 中山市一鸣电子材料有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119855607-A | Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application | 太阳雨林(北京)生物医药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-119768065-A | Composition comprising amyrin 3-acetate | 奇华顿股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| EP-0409939-A1 | USE OF POLYUNSATURATED FATTY ACID DERIVATIVES IN THE PREPARATION OF MEDICAMENTS WITH TYROSINE KINASE INHIBITING ACTIVITY | BIOSIGNAL Kutato Fejleszto Kft. (HU) | 1991-01-30 | — | — | EP | disclosed |
| WO-1990008130-A1 | POLYUNSATURATED FATTY ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, METHOD FOR THE PREPARATION THEREOF, AND THEIR USE AS MEDICAMENT | FOLLIGEN BUDAPEST LTD. (HU) | 1990-07-26 | — | — | WO | disclosed |
| US-4442090-A | ACYLATED AMINO ACID | KYOTO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) | 1984-04-10 | — | — | US | disclosed |
| US-4241085-A | N-ACYL-METHIONINE | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1980-12-23 | — | — | US | disclosed |
| US-4093740-A | N-ACYL-METHIONINE | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSIER (DT) | 1978-06-06 | — | — | US | disclosed |
| US-3971701-A | FATTY ACID, ESTER OR N-ACYLAMINO ACID SURFACTANT | AJINOMOTO CO., INC. (JA) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11319285-B2 | N-acylated methionine sulfoxides as food flavouring compounds | MTR, MGMT, TAS1R1 | NOD1 2366/4885FNTA 2082/4885FNTB 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.